Affiliation:
1. Pharmacoepidemiology and Health Risk Management Research Group, Medellin-Colombia
2. School of Medicine, CES University, Medellin-Colombia
3. Dermatology Research Group, CES University, Medellin-Colombia
Abstract
Background
The Dermatology Life Quality Index (DLQI) is a valuable tool for assessing the quality of life in adult patients with psoriasis.
Aims
To analyse the reliability and validity of the DLQI to measure the quality of life in patients with mild to moderate-severe psoriasis.
Methods
This was a secondary validation study nested in a follow-up study. The Rasch-Andrich model was utilised to perform response function, item and person fit, differential item functioning, dimensionality, and reliability analyses.
Results
A total of 1439 patients were analysed, 52.1% male, mean age of 48.7 years (SD 16.1). Psoriasis vulgaris was the phenotype in 43.1% of patients, and 86% had a mild Psoriasis Area Severity Index (PASI). Adequate adjustment of the response function and the items was observed in the best-fit sample, except for item 7 (work and study). The measure explained 60.9% of the variance and presented a reliability of 0.86. Differential item functioning was identified by age, with a relevant bias in the estimation for older adults. Item-person maps are provided.
Limitations
This study was performed at a single centre, with most patients presenting a mild PASI score, limiting generalisation of the findings.
Conclusion
The validity evidence favours the use of the DLQI in moderate-severe psoriasis. However, the instrument biases the estimate of older adults. This population group should consider a specific version of the instrument.
Subject
Infectious Diseases,Dermatology